Diabetic Ketoacidosis

Similar documents
Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives

Management of Hyperglycemic Crises

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS

AACN PCCN Review. Endocrine

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

Diabetic Ketoacidosis

Type 2 Diabetes Mellitus Insulin Therapy 2012

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate

Nothing to disclose. Disclosure

DRUG ALLERGIES WT: KG

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

Diabetic ketoacidosis and. adults. By Dr Karimifar Assistant Prof. of Endocrinology Isfahan University of Medical Sciences

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

Anne Leake, PhD, APRN, BC-ADM ECHO Diabetes Learning Group 4/4/18. High Sugar / Hyperglycemia: Causes, Complications and Management

Hyperosmolar Hyperglycemic State (HHS) Erica Kretchman DO October

With Dr. Sarah Reid and Dr. Sarah Curtis

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

I have no financial disclosures

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

Multiple c hoice q uestions

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

Published in

DKA Adult ICU Powerplan

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014

Diabetic Ketoacidosis. Raed Abu Sham a, M.D

DIABETES MELLITUS. IAP UG Teaching slides

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

For The Management Of. Diabetic Ketoacidosis

Learning Objectives. Perioperative SWEET Success

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set

Diabetes Related Emergencies

Obstetrics Guidelines. B. Maternal mortality rates are generally less than 1%.

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Diabetic Emergencies in Pregnancy. Brian A. Mason, MS, MD

Mixed Insulins Pick Me

Insulin Regimens: Hitting Glycemia Targets

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air

CCRN/PCCN Review Course May 30, 2013

Diagnosis and Management of DKA and Hyperglycemic, Hyperosmolar States

Hyperglycaemic Emergencies GRI EDUCATION

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

Diabetes in Pregnancy

Pathogenesis of disease diabetic ketoacidosis

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Disordered Glucose Metabolism

Pediatric Diabetic Ketoacidosis Guidelines

Country Health SA Local Health Network. Version control and change history

Management of adult diabetic ketoacidosis

Diabetic Ketoacidosis in Adults. Dr. Jessica Ross, Lakeridge Health Port Perry Katrina Manning, RN, BScN

Gen: Mild distress but A&O x 3. Heart: RHB, Lungs: OK 36.8, 120, 34, 132/88 HEENT: WNL. no rebound. Case 1 PE: No fever/chills, URI s/s

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor

DKA TREATMENT PROTOCOL Barbara Davis Center for Childhood Diabetes, University of Colorado & Children s Hospital Colorado

Nph insulin conversion to lantus

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS

Recent Advances in the Management of Diabetes

Improving Glycemic Control in the Critical Care

In-hospital management of diabetes

DIABETIC KETOACIDOSIS

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

Diabetic Ketoacidosis (DKA) v4.0: Links and Clinical Tools

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Managing DKA, HHS, & Hyperglycemia in Acute Care

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are

Table 1. Common precipitating events of DKA.

Insulin Prior Authorization with optional Quantity Limit Program Summary

I. General Considerations

DIABETES EMERGENCIES. Mary Bruskewitz, MS, APN, RN, BC-ADM Clinical Nurse Specialist - Diabetes. 12/1/2014 UWHealth 1

Supplement Table 1. Definitions for Causes of Death

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

George Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital

Diabetes: Inpatient Glucose control

Diabetic Ketoacidosis In Children JACQUELYN PETERS PHARMD CANDIDATE 2016 U OF W PHARMACY

DKA: Tripping on Acidosis

Deepika Reddy MD Department of Endocrinology

Adjusting Insulin Doses

The Mentally Altered Diabetic Diagnosis and Management of Hyperosmolar Hyperglycemic Syndrome Christy Michael, BVMS, MBA

HYPERGLYCEMIC CRISIS

Diabetic ketoacidosis Expiry date 2005

Pediatric non-diabetic ketoacidosis: a caseseries

Initiating Injectable Therapy in Type 2 Diabetes

Lynda Astbury Lead Diabetes Specialist Nurse

9/16/2013. No Conflict of Interest to Disclose

Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction

Clinical Guideline DKA

LETTER TO THE EDITOR

Diabetes Head to Toe May 31, 2017

4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Transcription:

October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent urination PMH: Negative Meds: None PE: BP 100/55 P 108 R 20 T 98.8 Deep rapid (Kussmaul) breathing Lab: Glucose 714 CO2 14 Ph 7.03 Ketones +160 K 4.9 Na 132 Cl 100 Anion Gap 18 Creat 1.4 Phos 4.5 Question 1 What is the most likely precipitating cause for diabetic ketoacidosis in this patient? A. Sepsis B. Dehydration C. Pulmonary Embolus D. Urinary Tract Infection E. New Onset Type 1 Diabetes

Besides insulin, what is the most important therapeutic intervention in DKA patients? A. Antibiotics B. Volume Repletion Question 2 C. Potassium Administration D. Phosphate Administration E. Bicarbonate Administration Question 3 What is the most common reason that a patient fails to respond to treatment for DKA? A. Use of SQ rather than IV insulin B. Use of ½ NS rather than NS C. Not treating the precipitating cause D. Failure to give bicarbonate E. Failure to give potassium Clinical Setting Type 1 DM (70-90%) New Onset Poor Compliance Precipitating Event Type 2 DM (10-30%) Precipitating Event

Precipitating Events Infection Adrenal Crisis Acute Abdomen Ischemic Extremity Pulmonary Embolus Myocardial Infarction Cerebrovascular Event New Onset Type 1 Diabetes Pathogenesis Insulin Deficiency Absolute h Counterregulatory Hormones Insulin Deficiency Relative h Lipolysis h Ketogenesis h Proteolysis h Gluconeogenesis i Glucose Utilization h Glycogenolysis Minimal Ketogenesis i Alkali Reserve Hyperglycemia Ketoacidosis Dehydration Hyperosmolarity DKA HHS Kitabchi A, Diabetes Care 2009;32:1335-43 SGLT2 Inhibitors May Cause DKA Taylor SI, J Clin Endocrinol Metab 2015; 100:2849-52

Water and Electrolyte Deficits Plasma Osmolality and Mental Status Plasma Osmolality Mental Status Kitabchi A, JCEM 2008;93:1541-52 Useful Calculations Anion Gap Na + -(Cl - + HCO3 - ) Normal Range: 7-13 mmol/l Serum Osmolality 2 x (Na + ) + (Glucose/18) + (BUN/2.8) Normal Range: 285-295 mosm/kg

Diagnosis Glucose > 250 mg/dl HCO3 < 18 meq/l ph < 7.30* Anion Gap > 15 Ketones Positive (Urine, Serum) *Arterial ph best but venous ph OK Severity DKA MILD MODERATE SEVERE Glucose: > 250 mg/dl ph: 7.25-7.30 HCO 3 : 15-18 meq/l Ketones: positive Sensorium: alert Glucose: > 250 mg/dl ph: 7.0-7.24 HCO 3 : 10-14 meq/l Ketones: positive Sensorium: alert/drowsy Glucose: > 250 mg/dl ph: < 7.0 HCO 3 : < 10 meq/l Ketones: positive Sensorium: stupor/coma HHS Glucose: > 600 mg/dl ph: > 7.30 HCO 3 : > 18 meq/l Ketones: small Sensorium: stupor/coma Kitabchi A, Diabetes Care. 2009;32:1335-43 IV Fluids Rehydrate: Monitor + Correct Hyponatremia Insulin Correct Hyperglycemia Potassium Prevent Hypokalemia Bicarbonate? Correct Severe Acidosis (ph < 6.9) Treat Precipitating Cause

IV Fluids 1 st Hour: NS, 15 20 ml/kg/h (1.0 1.5 Liters) Maintenance: ½ NS, 250 500 ml/h if serum Na h or Normal NS, 250-500 ml/h if serum Na Low Change to D5 when BG < 200 mg/dl (DKA) or < 300 mg/dl (HHS) Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51 Insulin (Regular) IV Bolus 0.1 U/kg, then Infusion 0.1 U/kg/hr If BG not i by 10% in 1 hour, IV bolus 0.14 U/kg and continue infusion at the previous rate Decrease rate to 0.02-0.05 U/kg/hr when BG < 200 mg/dl (DKA) or < 300 mg/dl (HHS) Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51 Insulin Given by Different Routes Mild-Moderate DKA RCT: IV vs SQ vs IM Insulin Glucose Ketones Conclusion: In Mild-Moderate DKA, Insulin May Be Given IV, SQ or IM Kitabchi A, JCEM 2008;93:1541-52

SQ insulin analogs may be used in mild moderate DKA in ED or inpatient Butkiewicz E, Diabetes Care 1995;18:1187 90 Fisher J, N Engl J Med 1977;297:238 47 Nyenwe E, Kitabchi A, Diab Res Clin Pract 2011; 94:340-51 IV Insulin + SQ Glargine RCT: IV Insulin vs IV Insulin + Glargine 0.25 U/Kg within 10 hours of IV Start Open Bars (N=13) No Glargine Closed Bars (N=12) Glargine Average Glucose Percent Rebound h Glucose Conclusion: In DKA, SQ Glargine Given with IV Insulin Reduces the Risk of Future Rebound Hyperglycemia without Increasing Hypoglycemia University of Colorado DKA Study Hsia E, J Clin Endocrinol Metab 2012;97:3132-7 Potassium (check every 2 hours) Serum K + > 5.2 meq/l: Don t give K + Serum K + 3.3-5.1 meq/l: Give K + 20-30 meq/l Serum K + < 3.3 meq/l initially: Delay Insulin Rx. Give K + 20-30 meq/h until serum K + > 3.3 meq/l Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51

Bicarbonate ph < 6.9: Na Bicarbonate, 2 amps (100 mmol) in 400 ml H20 with 20 meq KCL, at rate of 200 ml/h for 2 hr until the venous ph is > 7.0 ph > 6.9: Na Bicarbonate therapy not required Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51 Phosphate Not indicated in most DKA patients Potential hypophosphatemic complications: Add 20 30 meq/l K Phosphate to IV fluids Monitor serum calcium level Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51 Hypercoagulable State DKA: prophylactic heparin use may be beneficial HHS: full anticoagulation if no contraindications Kitabchi A, Diabetes Care 2009;32:1335 43 Nyenwe E, Diab Res Clin Pract 2011; 94:340-51

Glucose < 200 mg/dl HCO3 > 18 meq/l ph > 7.30 Resolution Anion Gap < 13 Ketones Negative (Urine, Serum) Ketone Response to Nitroprusside Measures Acetoacetate B Hydroxybutyrate Predominates Early; Converts to Acetoacetate With Caveat Ketones Measured by NP May Worsen Transiently Before Improving Protocol Use One Kitabchi A, Diabetes Care 2009;32:1335-43

UCH Protocol Use One Flowsheet Use One Precipitating Cause: don t fail to treat Cerebral Edema: don t correct BG too rapidly Pitfalls of Relapse: don t turn off the IV insulin too soon Relapse: remember to give SQ long acting insulin before you stop the IV insulin

Mortality Mortality DKA: ~ 4% HHS: ~ 15% Adverse Prognostic Factors Coma Hypotension Age Extremes Case History He is given a 7 U (0.1 U/kg) insulin bolus and a 7 U/hr (0.1 U/kg/hr) insulin infusion and NS with 40 meq/l KCl at 250 cc/hr IV. The DKA resolves after 6 liters of fluid and 74 U of insulin over 24 hrs. During the next 24 hrs, he is kept on a low dose insulin infusion rate of 0.7 U/hr and is given a total of 15 U of short acting insulin to cover meals and hyperglycemia (24 hr insulin = 32 U). 24 Hour Insulin Requirement: 32 Units What regimen would you start prior to discharge? q Glargine insulin Dose: q Detemir insulin Dose: q Lispro insulin Dose: q Aspart insulin Dose: q Glulisine insulin Dose: q NPH insulin Dose: q Regular insulin Dose: Glargine = Lantus Detemir = Levemir Lispro = Humalog Aspart = Novolog Glulisine = Apidra

24 Hour Insulin Requirement: 32 Units What regimen would you start prior to discharge? q Glargine insulin Dose: 15 U or q Detemir insulin Dose: 15 U q Lispro insulin Dose: 5 U or q Aspart insulin Dose: 5 U or q Glulisine insulin Dose: 5 U Uninsured and/or can t afford insulin analogs: q NPH insulin Dose: 14 AM, 6 PM q Regular insulin Dose: 6 AM, 6 PM Analog Insulin: Basal - 50% TDD; Boluses - 50% TDD Human Insulin: AM 2/3 TDD (2/3 N, 1/3 R); PM 1/3 TDD (1/2 N, 1/2 R) Summary Find Precipitating Cause Treat with Insulin, Volume Repletion, KCl Monitor Closely and Use a Flow Sheet Transition to SQ Insulin before DC IV Insulin Discharge Patient on Insulin Follow-up after Hospital Discharge Thank You